Their own mini-boom of recent years has been largely fueled by one firm, Ozempic maker Novo Nordisk A/S, whose diabetes and ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare should cover them.

Wellness influencer Janelle Rohner reveals she is 'microdosing' GLP-1 medication for weight loss and addresses criticism over ...

Cheung, one of Trump's closest allies, reffered to Coles as a "piece of sh*t" after she speculated the president might not be ...

Health and wellness influencer Janelle Rohner has received backlash after revealing in a YouTube video posted on April 23 ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risks.

Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.

Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...

Wegovy, Ozempic and Zepbound are normally used to help shed some pounds, but experts said that can come at a cost for those ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

Shares of WW International, formerly known as Weight Watchers, more than doubled after the company received a letter from an activist investor arguing against a Chapter 11 bankruptcy filing. The ...